Taken together, our data suggest that in tissue microenvironments sustaining the activation and division of leukemic B cells, the functional program of Th17s in CLL might be distinct from that seen in healthy subjects, favoring IL-17F production. This evidence concerns the gene IL17F and B-cell chronic lymphocytic leukemia.